HBV感染免疫耐受期肝组织炎症和纤维化的影响因素分析
目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价，为免疫耐受期患者的病情判断提供依据。 方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例，收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV DNA等资料，并对患者的肝组织行病理检查，根据炎症分级分为两组(G＜2组和G≥2组)，根据纤维化程度分为两组(S＜2组和S≥2组)。计量资料2组间比较采用t检验，使用单因素和多因素非条件logistic回归分析肝组织病理炎症活动≥G2和纤维化程度≥S2的影响因素。 结果 300例...
Saved in:
| Published in | Linchuang gandanbing zazhi Vol. 38; no. 9; pp. 2005 - 2009 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | Chinese |
| Published |
Changchun
Journal of Clinical Hepatology
01.09.2022
昆明市第三人民医院肝病科,云南省传染性疾病临床医学中心,昆明650041 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 2097-3497 |
| DOI | 10.3969/j.issn.1001-5256.2022.09.012 |
Cover
Loading…
| Abstract | 目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价，为免疫耐受期患者的病情判断提供依据。 方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例，收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV DNA等资料，并对患者的肝组织行病理检查，根据炎症分级分为两组(G＜2组和G≥2组)，根据纤维化程度分为两组(S＜2组和S≥2组)。计量资料2组间比较采用t检验，使用单因素和多因素非条件logistic回归分析肝组织病理炎症活动≥G2和纤维化程度≥S2的影响因素。 结果 300例患者中，G≥2组213例(71%)，S≥2组120例(40%)，基线年龄(26.06±9.01)岁，男性占48%，感染时间(5.62±5.09)年。单因素分析显示，G＜2组和G≥2组ALT、ALP、Alb、PLT、门静脉内径和脾脏厚度比较，差异均有统计学意义(t值分别为-26.677、-11.612、2.149、5.410、-6.092、-2.911，P值均＜0.05)；S＜2组与S≥2组比较，感染时间、ALT、ALP、Alb、HBV DNA、PLT、门静脉内径和脾脏厚度比较，差异均有统计学意义(t值分别为-6.320、-6.694、-7.880、2.349、4.552、19.160、-5.782、-5.622，P值均＜0.05)。多因素分析显示，ALT(OR=10.270，95%CI：2.212~47.672，P=0.003)、ALP(OR=1.097，95%CI：1.013~1.188，P=0.023)是免疫耐受期患者肝组织炎症≥G2的独立危险因子；ALP(OR=1.034，95%CI：1.015~1.054，P＜0.001)、PLT(OR=0.913，95%CI：0.886~0.938，P＜0.001)、HBV DNA(OR=0.198，95%CI：0.062~0.636，P=0.007)和感染时间(OR=1.176，95%CI：1.033~1.340，P=0.015)是免疫耐受期患者肝组织纤维化≥S2的独立影响因子。 结论 大多数免疫耐受期患者都有显著的肝组织学病变。ALT、ALP是免疫耐受期患者肝组织显著炎症的影响因素，ALP、HBV DNA、PLT和感染时间是免疫耐受期患者肝组织显著纤维化的影响因素。 |
|---|---|
| AbstractList | 目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价，为免疫耐受期患者的病情判断提供依据。 方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例，收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV DNA等资料，并对患者的肝组织行病理检查，根据炎症分级分为两组(G＜2组和G≥2组)，根据纤维化程度分为两组(S＜2组和S≥2组)。计量资料2组间比较采用t检验，使用单因素和多因素非条件logistic回归分析肝组织病理炎症活动≥G2和纤维化程度≥S2的影响因素。 结果 300例患者中，G≥2组213例(71%)，S≥2组120例(40%)，基线年龄(26.06±9.01)岁，男性占48%，感染时间(5.62±5.09)年。单因素分析显示，G＜2组和G≥2组ALT、ALP、Alb、PLT、门静脉内径和脾脏厚度比较，差异均有统计学意义(t值分别为-26.677、-11.612、2.149、5.410、-6.092、-2.911，P值均＜0.05)；S＜2组与S≥2组比较，感染时间、ALT、ALP、Alb、HBV DNA、PLT、门静脉内径和脾脏厚度比较，差异均有统计学意义(t值分别为-6.320、-6.694、-7.880、2.349、4.552、19.160、-5.782、-5.622，P值均＜0.05)。多因素分析显示，ALT(OR=10.270，95%CI：2.212~47.672，P=0.003)、ALP(OR=1.097，95%CI：1.013~1.188，P=0.023)是免疫耐受期患者肝组织炎症≥G2的独立危险因子；ALP(OR=1.034，95%CI：1.015~1.054，P＜0.001)、PLT(OR=0.913，95%CI：0.886~0.938，P＜0.001)、HBV DNA(OR=0.198，95%CI：0.062~0.636，P=0.007)和感染时间(OR=1.176，95%CI：1.033~1.340，P=0.015)是免疫耐受期患者肝组织纤维化≥S2的独立影响因子。 结论 大多数免疫耐受期患者都有显著的肝组织学病变。ALT、ALP是免疫耐受期患者肝组织显著炎症的影响因素，ALP、HBV DNA、PLT和感染时间是免疫耐受期患者肝组织显著纤维化的影响因素。 目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价,为免疫耐受期患者的病情判断提供依据.方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例,收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV DNA等资料,并对患者的肝组织行病理检查,根据炎症分级分为两组(G<2组和G≥2组),根据纤维化程度分为两组(S<2组和S≥2组).计量资料2组间比较采用t检验,使用单因素和多因素非条件logistic回归分析肝组织病理炎症活动≥G2和纤维化程度≥S2的影响因素.结果 300例患者中,G≥2组213例(71％),S≥2组120例(40％),基线年龄(26.06±9.01)岁,男性占48％,感染时间(5.62±5.09)年.单因素分析显示,G<2组和G≥2组ALT、ALP、Alb、PLT、门静脉内径和脾脏厚度比较,差异均有统计学意义(t值分别为-26.677、-11.612、2.149、5.410、-6.092、-2.911,P值均<0.05);S<2组与S≥2组比较,感染时间、ALT、ALP、Alb、HBV DNA、PLT、门静脉内径和脾脏厚度比较,差异均有统计学意义(t值分别为-6.320、-6.694、-7.880、2.349、4.552、19.160、-5.782、-5.622,P值均<0.05).多因素分析显示,ALT(OR=10.270,95％CI:2.212～47.672,P=0.003)、ALP(OR=1.097,95％CI:1.013～1.188,P=0.023)是免疫耐受期患者肝组织炎症≥G2的独立危险因子;ALP(OR=1.034,95％CI:1.015～1.054,P<0.001)、PLT(OR=0.913,95％CI:0.886～0.938,P<0.001)、HBV DNA(OR=0.198,95％CI:0.062～0.636,P=0.007)和感染时间(OR=1.176,95％CI:1.033～1.340,P=0.015)是免疫耐受期患者肝组织纤维化≥S2的独立影响因子.结论 大多数免疫耐受期患者都有显著的肝组织学病变.ALT、ALP是免疫耐受期患者肝组织显著炎症的影响因素,ALP、HBV DNA、PLT和感染时间是免疫耐受期患者肝组织显著纤维化的影响因素. |
| Author | 李俊义 李惠敏 刘春云 李卫昆 刘立 张映媛 高建鹏 祁燕伟 常丽仙 |
| AuthorAffiliation | 昆明市第三人民医院肝病科,云南省传染性疾病临床医学中心,昆明650041 |
| AuthorAffiliation_xml | – name: 昆明市第三人民医院肝病科,云南省传染性疾病临床医学中心,昆明650041 |
| Author_FL | QI Yanwei LI Junyi LI Huimin LI Weikun LIU Li CHANG Lixian LIU Chunyun ZHANG Yingyuan GAO Jianpeng |
| Author_FL_xml | – sequence: 1 fullname: LIU Chunyun – sequence: 2 fullname: CHANG Lixian – sequence: 3 fullname: LI Junyi – sequence: 4 fullname: QI Yanwei – sequence: 5 fullname: LI Weikun – sequence: 6 fullname: LI Huimin – sequence: 7 fullname: ZHANG Yingyuan – sequence: 8 fullname: GAO Jianpeng – sequence: 9 fullname: LIU Li |
| Author_xml | – sequence: 1 fullname: 刘春云 – sequence: 2 fullname: 常丽仙 – sequence: 3 fullname: 李俊义 – sequence: 4 fullname: 祁燕伟 – sequence: 5 fullname: 李卫昆 – sequence: 6 fullname: 李惠敏 – sequence: 7 fullname: 张映媛 – sequence: 8 fullname: 高建鹏 – sequence: 9 fullname: 刘立 |
| BookMark | eNpF0M9LAkEcBfAhDDLzr6hDl91m5ruzs3MsqQyELtVVdtdZUWQ1Nwk8hVh20JIEhX7poVunwFPSnzM7_hkZRp3e5cN78NZRIqyGEqEtgk0Qttgpm6UoCk2CMTEYZbZJMaUmFiYmdAUlKRbcAEvwBEr-mTWUjqKShxkBW1jMTqJsdu8sbo_j8UBd9_TwfX7VV_ej-Hk8b73oWVvPOrp1p0cd9dDVn296NlXdoX5sq68PNeipp4meTtTtTfza30CrgVuJZPo3U-j0YP8kkzVyx4dHmd2cUSNAqMG5HUjuUxfAZhJAeJhi33FFgRCgEnMqKNCC41uBkD73bIIdLgPOmGUz4UtIoe1l76UbBm5YzJerjXq4WMxX_GLBazZ_bsBiccKCbi5prV49b8jo4t8CBQGMCMeBbyprduE |
| ContentType | Journal Article |
| Copyright | 2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: 2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2022.09.012 |
| DatabaseName | ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitle | Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitle_FL | Influencing factors for liver inflammation and fibrosis in the immune-tolerant phase of HBV infection |
| EISSN | 2097-3497 |
| EndPage | 2009 |
| ExternalDocumentID | lcgdbzz202209012 |
| GrantInformation_xml | – fundername: 云南省科技厅应用基础研究项目 funderid: (2017FH001-88) |
| GroupedDBID | -05 3V. 5XA 5XF 7X7 7XB 88E 8FI 8FJ 8FK 92F 92I ABDBF ABJNI ABUWG ACGFS ACUHS AFKRA ALMA_UNASSIGNED_HOLDINGS AZQEC BENPR CCEZO CCPQU CIEJG CW9 DWQXO EAD EAP EOJEC ESX FYUFA K9. M1P OBODZ OK1 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI RNS TCJ TGQ U1G U5O 2B. 4A8 93N IPNFZ PSX RIG |
| ID | FETCH-LOGICAL-p1312-776fe7c2a3365e339b020c8a9d1132e0729232d8c4f9ec7b61087ef7554659ce3 |
| IEDL.DBID | BENPR |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 04:06:10 EDT 2025 Sat Aug 23 12:53:17 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | 危险因素 免疫耐受 乙型肝炎病毒 |
| Language | Chinese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p1312-776fe7c2a3365e339b020c8a9d1132e0729232d8c4f9ec7b61087ef7554659ce3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| OpenAccessLink | https://www.proquest.com/docview/3239351988?pq-origsite=%requestingapplication% |
| PQID | 3239351988 |
| PQPubID | 7350069 |
| PageCount | 5 |
| ParticipantIDs | wanfang_journals_lcgdbzz202209012 proquest_journals_3239351988 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-09-01 |
| PublicationDateYYYYMMDD | 2022-09-01 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Changchun |
| PublicationPlace_xml | – name: Changchun |
| PublicationTitle | Linchuang gandanbing zazhi |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2022 |
| Publisher | Journal of Clinical Hepatology 昆明市第三人民医院肝病科,云南省传染性疾病临床医学中心,昆明650041 |
| Publisher_xml | – name: Journal of Clinical Hepatology – name: 昆明市第三人民医院肝病科,云南省传染性疾病临床医学中心,昆明650041 |
| SSID | ssib051369456 ssib061082477 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 2.2892697 |
| Snippet | 目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价，为免疫耐受期患者的病情判断提供依据。 方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例，收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV... 目的 对慢性HBV感染免疫耐受期患者进行肝脏损伤程度及肝纤维化的评价,为免疫耐受期患者的病情判断提供依据.方法 随机选取昆明市第三人民医院2015年1月—2019年12月HBV DNA水平≥107 IU/mL、ALT≤40 U/L且临床资料完整者300例,收集其年龄、性别、感染HBV时间、血生化、HBsAg、HBV... |
| SourceID | wanfang proquest |
| SourceType | Aggregation Database |
| StartPage | 2005 |
| SubjectTerms | Hepatitis B Infections Inflammation Liver cirrhosis |
| Title | HBV感染免疫耐受期肝组织炎症和纤维化的影响因素分析 |
| URI | https://www.proquest.com/docview/3239351988 https://d.wanfangdata.com.cn/periodical/lcgdbzz202209012 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NSxtBFH9oQsVL8aOltjZY8Lq62fnYnVMx1hAKipRacpPd2VlLKfGbQk5F0upBW1FQ0Lbx0JungidD_5zN-Gd03mbSpJcel9ldljdv3v7ezHu_H8A0w_7hhKMAses6lFDhRK6iTuJTwZWSiSTYKLy4xCsr9GWVVe2G27Ytq-zGxCxQx-sS98hnScbVZVLk4PnGpoOqUXi6aiU0BiFvQnDAcpAvLSwtv-oBgqL7D1sLto32ARZkW6d9hG6sSLigPXYZZuAGUtx1rw3WCLysc7MT66n5nk4Jv0nKmUEPQzCNebDgYvZdtopn_g6ZXNTzMk5VVL_sg7P3PoS1JKyt9f3XyiNw3wLSqbmOB43CQP3tGAwt2iP3cahUSm_ajWa7eZp-OtJn13cfj9Ov5-1vzbu977rV0K19vfdFn--nJ4f69qdu3aSHZ_qikf7-lZ4epZdX-uYqPfjc_nH8AFbKC6_nK46VX3A2iqSIuJsnypdeSAhnihARGWgpg1DEqE6vkHLcwLE4kDQRSvoRGsdXiY91b0xIRR5CrrZeU49gKhZCcs84AQ8p7l4KJXjEYvNcEocmCZ-Aya49Vu0a2l7tzfgEPLM26o2-l2txVK-jUV2DabzH_3_FExjGWzvVYZOQ29naVU8NnNiJCjDoV_0C5OdKL0rlgvWgP1Xg1Tc |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQXtH04zA11AbGCga2JsYqmbZJBqoptmbmJplpqanJZsDNoo7Otn5hFq4hVhGsHEsA62Fwa0rBJWJoIL6pT8ZNAYub4x-KwuYBfZwr6gUBd0axRodhV2hQYkWXinVpYDu2zFtp4uwPhVNTJycw1x9tCF3iqgW2BobAhqTpqlpZonGyUaG5uZphobWyYBW0zJFomWKaBL11NBJ2kDWxkpFskmaZapyeZJwPaFhXlqmjloOZepZXKqMdBcZgZWYDPDEpiLWJ1c_QKCEA0QQwOU02FA21SRGkig091NkA6QMzU0NrM0QZxmYwps3oCO1IPxQXYbgXeKQuoWE6D_IVsGDAyBXUhTMw4GFVC_29LMUj8LXGrowaWAfV8jI_AZrqDbNpGaz-zliXlpiXnpSPWomyADP7QBrOAISbFCDExVGcIMHL7QKX4RBg8Pp7BnLfOfzZ_8tLX3-bTVLxomPO2f_mzO_BdNc5_vbnm-u_15U9_z6e1PJ_U837Xk-e4tT3umPZ_V8nTvxqeTe5_OXvB8y4KnHW3P5k0QZQilScSIMbDk5eelSjAopFhaJpsZAROdWaIJaLTUMtXSLMk0BagvLSUR2OmXZJCBhUc8NM8WxyNSmCSDIjSMELI5yekpSVVVoEA1ALahjKTwGyHPwOkR4usT7-Pp5y3NwAXSBlmZJsPAUlJUmioLbMqUJMlB048CQwKtkywAsuAN0A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HBV%E6%84%9F%E6%9F%93%E5%85%8D%E7%96%AB%E8%80%90%E5%8F%97%E6%9C%9F%E8%82%9D%E7%BB%84%E7%BB%87%E7%82%8E%E7%97%87%E5%92%8C%E7%BA%A4%E7%BB%B4%E5%8C%96%E7%9A%84%E5%BD%B1%E5%93%8D%E5%9B%A0%E7%B4%A0%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%88%98%E6%98%A5%E4%BA%91&rft.au=%E5%B8%B8%E4%B8%BD%E4%BB%99&rft.au=%E6%9D%8E%E4%BF%8A%E4%B9%89&rft.au=%E7%A5%81%E7%87%95%E4%BC%9F&rft.date=2022-09-01&rft.pub=%E6%98%86%E6%98%8E%E5%B8%82%E7%AC%AC%E4%B8%89%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E8%82%9D%E7%97%85%E7%A7%91%2C%E4%BA%91%E5%8D%97%E7%9C%81%E4%BC%A0%E6%9F%93%E6%80%A7%E7%96%BE%E7%97%85%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E4%B8%AD%E5%BF%83%2C%E6%98%86%E6%98%8E650041&rft.issn=1001-5256&rft.volume=38&rft.issue=9&rft.spage=2005&rft.epage=2009&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2022.09.012&rft.externalDocID=lcgdbzz202209012 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |